cefuroxime has been researched along with Chronic Disease in 42 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We started therapy sinusitis of our patients with antibiotics cefuroxime axetil (Zinnat, GSK), clarithromycin (Klacid Uno, Abbott) and orally given steroid-prednisone in one group (A+S) 56 patients." | 9.11 | [Chronic sinusitis therapy with antibiotics (axetyl cefuroxym, clarithromycin) and steroid (prednisone)]. ( Klatka, J; Obszańska, B; Polberg, K; Remer, M, 2005) |
| "A randomized, double-blind, double-dummy, three-arm parallel design, multicentre study was conducted among adult patients with acute exacerbation of chronic bronchitis (AECB) in order to compare the efficacy and safety of two different doses of levofloxacin with cefuroxime axetil." | 9.09 | Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study. ( Dolmann, A; Fiss, E; Maesen, FP; Shah, PM; Vetter, N; Wesch, R, 1999) |
| "The objective of this randomized, double-blind study was to compare the clinical efficacy of levofloxacin at two different dosages with that of cefuroxime axetil in patients with acute purulent exacerbations of chronic bronchitis and, in particular, to assess the impact of the susceptibility to levofloxacin on the clinical findings." | 9.09 | Clinical effectiveness of levofloxacin in patients with acute purulent exacerbations of chronic bronchitis: the relationship with in-vitro activity. ( Davies, BI; Maesen, FP, 1999) |
| "The bacteriological eradication rates of Streptococcus pneumoniae from sputum of patients experiencing acute exacerbations of chronic bronchitis (WHO definition) have been compared following therapy with either cefuroxime axetil 250 mg b." | 9.09 | Bacteriological eradication of Streptococcus pneumoniae from patients with acute exacerbations of chronic bronchitis: cefuroxime axetil versus cefixime. ( Geslin, P; Leblanc, F; Petitpretz, P; Rio, Y; Zuck, P, 1999) |
| "The addition of fluticasone to xylometazoline and antimicrobial therapy with cefuroxime improves clinical success rates and accelerates recovery of patients with a history of chronic rhinitis or recurrent sinusitis who present for treatment of acute rhinosinusitis." | 9.09 | Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial. ( Califf, RM; Dolor, RJ; Hellkamp, AS; Simel, DL; Williams, JW; Witsell, DL, 2001) |
| "A prospective, multicentre, randomized, open-label, parallel group study compared the efficacy, safety and tolerability of cefuroxime 750 mg iv administered either twice daily (bd) or three times daily (tds) for 48-72 h, followed by oral cefuroxime axetil 500 mg bd for 5-7 days in a sequential therapy regimen for the treatment of acute exacerbations of chronic bronchitis." | 9.08 | Sequential therapy with cefuroxime followed by cefuroxime axetil in acute exacerbations of chronic bronchitis. ( Droszcz, W; Marr, C; Reisenberg, K; Staley, H; Vogel, F; Vondra, V, 1997) |
| "In a prospective, multicenter, double-blind study, the interval to clinical relapse in patients with acute bacterial exacerbations of chronic bronchitis from whom a pretherapy pathogen was isolated was compared following treatment with ciprofloxacin or cefuroxime axetil." | 9.08 | Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group. ( Aneiro, L; Chodosh, S; Drehobl, M; Farkas, S; Kowalsky, S; McCarty, J; Shan, M; Tosiello, R, 1998) |
| "128 Patients (45 female, 83 male) with acute exacerbations of chronic bronchitis were treated with either cefuroxime axetil 2 x 500 mg/d (n = 65) or ofloxacin 2 x 200 mg/d for 7-8 days in a randomized controlled multicenter trial." | 9.07 | [Treatment of acute exacerbations of chronic bronchitis. Multicenter, randomized comparative study of cefuroxime axetil versus ofloxacin]. ( Kleckow, M, 1991) |
| "Cefuroxime axetil is a beta-lactamase-stable, second-generation, oral cephalosporin that penetrates sinus tissue in concentrations exceeding the MIC90 values (the minimum concentration of drug needed to inhibit the growth of 90% of an isolate of a particular microorganism) for pathogens most commonly associated with acute sinusitis, including Streptococcus pneumoniae and Haemophilus influenzae." | 8.79 | Cefuroxime axetil in the treatment of sinusitis. A review. ( Collins, JJ; Graham, JA; Pakes, GE; Rauch, AM, 1994) |
| " The study was undertaken to determine the concentrations of cefuroxime in the blood and middle ear effusions (MEE) of children between 6 and 12 years of age with acute otitis media and chronic OME after a single oral dose administration of cefuroxime axetil, the ester prodrug of cefuroxime." | 7.68 | Concentration of cefuroxime in serum and middle ear effusion after single dose treatment with cefuroxime axetil. ( Bluestone, CD; Collins, JJ; Haddad, J; Hart, RW; Isaacson, G; Respler, DS; Yilmaz, HM, 1991) |
| "Twenty-four atopic children with allergic rhinitis, asthma and maxillary sinusitis were treated with a combination of cefuroxime 50-80 mg/kg/day and N-acetyl-cysteine 15-25 mg/kg/day administered intramuscularly for 10 days." | 7.67 | A combination of cefuroxime and N-acetyl-cysteine for the treatment of maxillary sinusitis in children with respiratory allergy. ( Andreoli, A; Baronio, L; Boner, AL; Valletta, EA; Vallone, G, 1984) |
| "Sixty-five patients, 25 with acute bronchopulmonary respiratory tract diseases and 40 with acute exacerbations of chronic respiratory tract infections, were treated by means of intramuscular injection of an extempore combination of 1 g of cefuroxime and 300 mg of acetylcysteine." | 7.67 | Acute and exacerbated chronic respiratory tract infections: treatment with a combination of cefuroxime and acetylcysteine. ( Dal Negro, RW; Pomari, C; Trevisan, F; Turco, P; Zoccatelli, O, 1985) |
| "Free cefuroxime has been obtained by equilibrium dialysis and measured by HPLC." | 5.28 | [Binding of cefuroxime to macromolecules from bronchitic sputum in patients with chronic bronchitis]. ( Chiche, D; Houdret, N; Lhermitte, M; Roussel, P, 1991) |
| "We started therapy sinusitis of our patients with antibiotics cefuroxime axetil (Zinnat, GSK), clarithromycin (Klacid Uno, Abbott) and orally given steroid-prednisone in one group (A+S) 56 patients." | 5.11 | [Chronic sinusitis therapy with antibiotics (axetyl cefuroxym, clarithromycin) and steroid (prednisone)]. ( Klatka, J; Obszańska, B; Polberg, K; Remer, M, 2005) |
| "A randomized, double-blind, double-dummy, three-arm parallel design, multicentre study was conducted among adult patients with acute exacerbation of chronic bronchitis (AECB) in order to compare the efficacy and safety of two different doses of levofloxacin with cefuroxime axetil." | 5.09 | Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study. ( Dolmann, A; Fiss, E; Maesen, FP; Shah, PM; Vetter, N; Wesch, R, 1999) |
| "The objective of this randomized, double-blind study was to compare the clinical efficacy of levofloxacin at two different dosages with that of cefuroxime axetil in patients with acute purulent exacerbations of chronic bronchitis and, in particular, to assess the impact of the susceptibility to levofloxacin on the clinical findings." | 5.09 | Clinical effectiveness of levofloxacin in patients with acute purulent exacerbations of chronic bronchitis: the relationship with in-vitro activity. ( Davies, BI; Maesen, FP, 1999) |
| "A randomized, open, multiple-dose, pharmacological study, employing cefuroxime axetil, an approved oral antimicrobial for the treatment of acute bacterial rhinosinusitis, was developed." | 5.09 | Penetration of cefuroxime into chronically inflamed sinus mucosa. ( Dinis, PB; Gomes, A; Lobato, R; Martins, ML; Monteiro, MC, 1999) |
| "The bacteriological eradication rates of Streptococcus pneumoniae from sputum of patients experiencing acute exacerbations of chronic bronchitis (WHO definition) have been compared following therapy with either cefuroxime axetil 250 mg b." | 5.09 | Bacteriological eradication of Streptococcus pneumoniae from patients with acute exacerbations of chronic bronchitis: cefuroxime axetil versus cefixime. ( Geslin, P; Leblanc, F; Petitpretz, P; Rio, Y; Zuck, P, 1999) |
| "The addition of fluticasone to xylometazoline and antimicrobial therapy with cefuroxime improves clinical success rates and accelerates recovery of patients with a history of chronic rhinitis or recurrent sinusitis who present for treatment of acute rhinosinusitis." | 5.09 | Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial. ( Califf, RM; Dolor, RJ; Hellkamp, AS; Simel, DL; Williams, JW; Witsell, DL, 2001) |
| " We have investigated the impact on normal human intestinal flora in a 10-day course with cefetamet-pivoxil (CET, 500 mg BID) in comparison to cefixime (CFX, 400 mg qD) or cefuroxime axetil (CA, 250 mg BID) in 24 patients suffering from acute exacerbation of chronic bronchitis." | 5.08 | Betalactam therapy and intestinal flora. ( Cassetta, MI; Conti, S; Dei, R; Fallani, S; Mazzei, T; Novelli, A, 1995) |
| "A prospective, multicentre, randomized, open-label, parallel group study compared the efficacy, safety and tolerability of cefuroxime 750 mg iv administered either twice daily (bd) or three times daily (tds) for 48-72 h, followed by oral cefuroxime axetil 500 mg bd for 5-7 days in a sequential therapy regimen for the treatment of acute exacerbations of chronic bronchitis." | 5.08 | Sequential therapy with cefuroxime followed by cefuroxime axetil in acute exacerbations of chronic bronchitis. ( Droszcz, W; Marr, C; Reisenberg, K; Staley, H; Vogel, F; Vondra, V, 1997) |
| "In a prospective, multicenter, double-blind study, the interval to clinical relapse in patients with acute bacterial exacerbations of chronic bronchitis from whom a pretherapy pathogen was isolated was compared following treatment with ciprofloxacin or cefuroxime axetil." | 5.08 | Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group. ( Aneiro, L; Chodosh, S; Drehobl, M; Farkas, S; Kowalsky, S; McCarty, J; Shan, M; Tosiello, R, 1998) |
| "128 Patients (45 female, 83 male) with acute exacerbations of chronic bronchitis were treated with either cefuroxime axetil 2 x 500 mg/d (n = 65) or ofloxacin 2 x 200 mg/d for 7-8 days in a randomized controlled multicenter trial." | 5.07 | [Treatment of acute exacerbations of chronic bronchitis. Multicenter, randomized comparative study of cefuroxime axetil versus ofloxacin]. ( Kleckow, M, 1991) |
| "Cefuroxime axetil is a beta-lactamase-stable, second-generation, oral cephalosporin that penetrates sinus tissue in concentrations exceeding the MIC90 values (the minimum concentration of drug needed to inhibit the growth of 90% of an isolate of a particular microorganism) for pathogens most commonly associated with acute sinusitis, including Streptococcus pneumoniae and Haemophilus influenzae." | 4.79 | Cefuroxime axetil in the treatment of sinusitis. A review. ( Collins, JJ; Graham, JA; Pakes, GE; Rauch, AM, 1994) |
| " The study was undertaken to determine the concentrations of cefuroxime in the blood and middle ear effusions (MEE) of children between 6 and 12 years of age with acute otitis media and chronic OME after a single oral dose administration of cefuroxime axetil, the ester prodrug of cefuroxime." | 3.68 | Concentration of cefuroxime in serum and middle ear effusion after single dose treatment with cefuroxime axetil. ( Bluestone, CD; Collins, JJ; Haddad, J; Hart, RW; Isaacson, G; Respler, DS; Yilmaz, HM, 1991) |
| "Twenty-four atopic children with allergic rhinitis, asthma and maxillary sinusitis were treated with a combination of cefuroxime 50-80 mg/kg/day and N-acetyl-cysteine 15-25 mg/kg/day administered intramuscularly for 10 days." | 3.67 | A combination of cefuroxime and N-acetyl-cysteine for the treatment of maxillary sinusitis in children with respiratory allergy. ( Andreoli, A; Baronio, L; Boner, AL; Valletta, EA; Vallone, G, 1984) |
| "Sixty-five patients, 25 with acute bronchopulmonary respiratory tract diseases and 40 with acute exacerbations of chronic respiratory tract infections, were treated by means of intramuscular injection of an extempore combination of 1 g of cefuroxime and 300 mg of acetylcysteine." | 3.67 | Acute and exacerbated chronic respiratory tract infections: treatment with a combination of cefuroxime and acetylcysteine. ( Dal Negro, RW; Pomari, C; Trevisan, F; Turco, P; Zoccatelli, O, 1985) |
| "Cefuroxime has shown good clinical efficacy and tolerance in lower respiratory tract infections." | 2.38 | [Parenteral cephalosporins for the treatment of lower respiratory tract infections]. ( Vogel, F, 1993) |
| "Free cefuroxime has been obtained by equilibrium dialysis and measured by HPLC." | 1.28 | [Binding of cefuroxime to macromolecules from bronchitic sputum in patients with chronic bronchitis]. ( Chiche, D; Houdret, N; Lhermitte, M; Roussel, P, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (16.67) | 18.7374 |
| 1990's | 20 (47.62) | 18.2507 |
| 2000's | 12 (28.57) | 29.6817 |
| 2010's | 3 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, C | 1 |
| Kahl, BC | 1 |
| Olesen, HV | 1 |
| Jensen-Fangel, S | 1 |
| Nørskov-Lauritsen, N | 1 |
| Mitty, J | 1 |
| Margolius, D | 1 |
| Diefenbeck, M | 1 |
| Mennenga, U | 1 |
| Gückel, P | 1 |
| Tiemann, AH | 1 |
| Mückley, T | 1 |
| Hofmann, GO | 1 |
| Mischnik, A | 1 |
| Zimmermann, S | 1 |
| Bekeredjian-Ding, I | 1 |
| Egermann, M | 1 |
| Namyslowski, G | 1 |
| Misiolek, M | 1 |
| Czecior, E | 1 |
| Malafiej, E | 1 |
| Orecka, B | 1 |
| Namyslowski, P | 1 |
| Misiolek, H | 1 |
| Mohanty, SP | 1 |
| Kumar, MN | 1 |
| Murthy, NS | 1 |
| Namysłowski, W | 1 |
| Namysłowski, G | 1 |
| Buszman, E | 1 |
| Misiołek, M | 1 |
| Remer, M | 1 |
| Polberg, K | 1 |
| Obszańska, B | 1 |
| Klatka, J | 1 |
| Wcisło-Dziadecka, D | 1 |
| Brzezińska-Wcisło, L | 1 |
| Krauze, E | 1 |
| Lis-Swiety, A | 1 |
| García-Alvarez, F | 2 |
| Monzón, M | 2 |
| Grasa, JM | 1 |
| Laclériga, A | 2 |
| Amorena, B | 2 |
| García-Alvarez, I | 1 |
| Navarro-Zorraquino, M | 1 |
| Alvarez, FG | 1 |
| Molotkov, VN | 1 |
| Chernushenko, EF | 1 |
| Maliuk, VM | 1 |
| Zhukovskiĭ, LI | 1 |
| Bil'ko, IP | 1 |
| Boner, AL | 1 |
| Valletta, EA | 1 |
| Andreoli, A | 1 |
| Vallone, G | 1 |
| Baronio, L | 1 |
| Gowland Hopkins, NF | 1 |
| Jamieson, CW | 1 |
| Trollfors, B | 1 |
| Alestig, K | 1 |
| Carlsten, C | 1 |
| Norrby, R | 1 |
| Friedman, WH | 1 |
| Katsantonis, GP | 1 |
| Bumpous, JM | 1 |
| Pakes, GE | 1 |
| Graham, JA | 1 |
| Rauch, AM | 1 |
| Collins, JJ | 2 |
| Droszcz, P | 1 |
| Doboszyńska, A | 1 |
| Zielonka, TM | 1 |
| Ketterl, R | 1 |
| Wittwer, W | 1 |
| Vogel, F | 2 |
| Novelli, A | 1 |
| Mazzei, T | 1 |
| Fallani, S | 1 |
| Dei, R | 1 |
| Cassetta, MI | 1 |
| Conti, S | 1 |
| Markiewicz, K | 1 |
| Tatoń, J | 1 |
| Trippenbach, T | 1 |
| Raźna, I | 1 |
| Bart, BIa | 1 |
| Solov'ev, SS | 1 |
| Zaseeva, OV | 1 |
| Benevskaia, VF | 1 |
| Mikhaĭlusova, MP | 1 |
| Romanova, MV | 1 |
| Kasatikova, LA | 1 |
| Droszcz, W | 1 |
| Vondra, V | 1 |
| Reisenberg, K | 1 |
| Marr, C | 1 |
| Staley, H | 1 |
| Ribas, J | 1 |
| Lores, L | 1 |
| Ruiz, J | 1 |
| Ausina, V | 1 |
| Morera, J | 1 |
| Chodosh, S | 1 |
| McCarty, J | 1 |
| Farkas, S | 1 |
| Drehobl, M | 1 |
| Tosiello, R | 1 |
| Shan, M | 1 |
| Aneiro, L | 1 |
| Kowalsky, S | 1 |
| Shah, PM | 1 |
| Maesen, FP | 2 |
| Dolmann, A | 1 |
| Vetter, N | 1 |
| Fiss, E | 1 |
| Wesch, R | 1 |
| Davies, BI | 1 |
| Dinis, PB | 1 |
| Monteiro, MC | 1 |
| Lobato, R | 1 |
| Martins, ML | 1 |
| Gomes, A | 1 |
| Zuck, P | 1 |
| Petitpretz, P | 1 |
| Geslin, P | 1 |
| Rio, Y | 1 |
| Leblanc, F | 1 |
| Van Herwaarden, CL | 1 |
| Langan, CE | 1 |
| Siemon, G | 1 |
| Rudolph, C | 1 |
| Keyserling, CH | 1 |
| Nemeth, MA | 1 |
| Tack, KJ | 1 |
| Bogdanov, MB | 1 |
| Chernen'kaia, TV | 1 |
| Gracia, E | 1 |
| Leiva, J | 1 |
| Oteiza, C | 1 |
| Woolhouse, IS | 1 |
| Hill, SL | 1 |
| Stockley, RA | 1 |
| Dolor, RJ | 1 |
| Witsell, DL | 1 |
| Hellkamp, AS | 1 |
| Williams, JW | 1 |
| Califf, RM | 1 |
| Simel, DL | 1 |
| Pines, A | 1 |
| Raafat, H | 1 |
| Landau, Z | 1 |
| Schlaffer, F | 1 |
| Pitlik, S | 1 |
| Marcos Sánchez, F | 1 |
| Llorente Domingo, P | 1 |
| Celdran Gil, J | 1 |
| Durán Pérez-Navarro, A | 1 |
| Lhermitte, M | 1 |
| Chiche, D | 1 |
| Houdret, N | 1 |
| Roussel, P | 1 |
| Kleckow, M | 1 |
| Haddad, J | 1 |
| Isaacson, G | 1 |
| Respler, DS | 1 |
| Hart, RW | 1 |
| Yilmaz, HM | 1 |
| Bluestone, CD | 1 |
| Girbino, G | 1 |
| Giacobbe, G | 1 |
| Arsena, A | 1 |
| Ferrara, F | 1 |
| Dal Negro, RW | 1 |
| Turco, P | 1 |
| Zoccatelli, O | 1 |
| Pomari, C | 1 |
| Trevisan, F | 1 |
3 reviews available for cefuroxime and Chronic Disease
| Article | Year |
|---|---|
Updates and controversies in the treatment of Lyme disease.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Chronic Disease; Diagnosis, Different | 2008 |
Cefuroxime axetil in the treatment of sinusitis. A review.
Topics: Acute Disease; Anti-Bacterial Agents; Bacterial Infections; Cefuroxime; Chronic Disease; Clinical Tr | 1994 |
[Parenteral cephalosporins for the treatment of lower respiratory tract infections].
Topics: Bronchitis; Cefuroxime; Cephalosporins; Chronic Disease; Cross Infection; Humans; Infusions, Intrave | 1993 |
18 trials available for cefuroxime and Chronic Disease
| Article | Year |
|---|---|
Comparison of the efficacy and tolerability of amoxycillin/clavulanic acid 875 mg b.i.d. with cefuroxime 500 mg b.i.d. in the treatment of chronic and acute exacerbation of chronic sinusitis in adults.
Topics: Administration, Oral; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; C | 2002 |
[Chronic sinusitis therapy with antibiotics (axetyl cefuroxym, clarithromycin) and steroid (prednisone)].
Topics: Anti-Infective Agents; Cefuroxime; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Femal | 2005 |
[Place of ketocef in treating chronic bronchitis and its effect on the patient's body].
Topics: Adult; B-Lymphocytes; Bronchitis; Cefuroxime; Cephalosporins; Chloramphenicol; Chronic Disease; Clin | 1983 |
[Possibilities for the use of the basic cephalosporin cefuroxime in bone surgery. Tissue levels, effectiveness and tolerance].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Bone and Bones; Cefuroxime; Chroni | 1993 |
Betalactam therapy and intestinal flora.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria, Anaerobic; Br | 1995 |
[The use of the cephalosporin antibiotic Zinnat under polyclinic conditions in treating patients with bronchopulmonary infections].
Topics: Acute Disease; Adolescent; Adult; Ambulatory Care; Bronchitis; Cefuroxime; Cephalosporins; Chronic D | 1996 |
Sequential therapy with cefuroxime followed by cefuroxime axetil in acute exacerbations of chronic bronchitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; Bronchitis; Cardiovascular Diseases; Cefuroxim | 1997 |
Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
Topics: Acute Disease; Adolescent; Adult; Anti-Infective Agents; Bronchitis; Cefuroxime; Cephalosporins; Chr | 1998 |
Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Cefuroxime; Cephalosporins; Chron | 1999 |
Clinical effectiveness of levofloxacin in patients with acute purulent exacerbations of chronic bronchitis: the relationship with in-vitro activity.
Topics: Aged; Anti-Infective Agents; Bronchitis; Cefuroxime; Cephalosporins; Chronic Disease; Double-Blind M | 1999 |
Penetration of cefuroxime into chronically inflamed sinus mucosa.
Topics: Adult; Aged; Cefuroxime; Cephalosporins; Chronic Disease; Female; Humans; Male; Microbial Sensitivit | 1999 |
Bacteriological eradication of Streptococcus pneumoniae from patients with acute exacerbations of chronic bronchitis: cefuroxime axetil versus cefixime.
Topics: Adult; Aged; Aged, 80 and over; Bronchitis; Cefixime; Cefuroxime; Cephalosporins; Chronic Disease; D | 1999 |
International study comparing cefdinir and cefuroxime axetil in the treatment of patients with acute exacerbation of chronic bronchitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Bacterial Infections; B | 2000 |
Symptom resolution assessed using a patient directed diary card during treatment of acute exacerbations of chronic bronchitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Analysis of Variance; Androstadienes; Anti-Inflammato | 2001 |
Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial.
Topics: Acute Disease; Administration, Intranasal; Adult; Androstadienes; Anti-Inflammatory Agents; Cefuroxi | 2001 |
Cefuroxime in severe respiratory infections: a double-blind comparison of two doses.
Topics: Bronchiectasis; Bronchitis; Cefuroxime; Cephalosporins; Chronic Disease; Clinical Trials as Topic; D | 1979 |
Cefuroxime axetil vs. augmentin for the treatment of acute bronchitis and exacerbation of chronic obstructive pulmonary disease.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bronchitis; Cefuroxime; Chi-Square Distr | 1992 |
[Treatment of acute exacerbations of chronic bronchitis. Multicenter, randomized comparative study of cefuroxime axetil versus ofloxacin].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Bronchitis; Cefuroxime; Chronic Di | 1991 |
21 other studies available for cefuroxime and Chronic Disease
| Article | Year |
|---|---|
Intravenous antibiotics given for 2 weeks do not eradicate persistent Staphylococcus aureus clones in cystic fibrosis patients.
Topics: Administration, Intravenous; Adolescent; Adult; Anti-Bacterial Agents; Cefuroxime; Child; Child, Pre | 2014 |
[Vacuum-assisted closure therapy for the treatment of acute postoperative osteomyelitis].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cefuroxime; Chronic Dis | 2011 |
Relapse of posttraumatic osteomyelitis due to Clostridium celerecrescens.
Topics: Administration, Oral; Anti-Bacterial Agents; Cefuroxime; Chronic Disease; Clindamycin; Clostridium; | 2011 |
Use of antibiotic-loaded polymethyl methacrylate beads in the management of musculoskeletal sepsis--a retrospective study.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bone Cements; Cefuroxime; Chronic Disease; Drug Implants; | 2003 |
[Evaluation of drug sensitivity of the microorganisms isolated from chronic sinusitis treated by beta lactam antibiotics].
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefuroxime; Chronic Disease; D | 2003 |
[Diagnostic and therapeutic difficultes in pityriasis rubra pilaris--case report].
Topics: Acitretin; Anti-Bacterial Agents; Anti-Inflammatory Agents; Calcium Carbonate; Cefuroxime; Chronic D | 2005 |
Interleukin-1, interleukin-6, and interleukin-10 responses after antibiotic treatment in experimental chronic Staphylococcus aureus osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cefuroxime; Chronic Disease; Ciprofloxacin; Disease Models | 2006 |
A combination of cefuroxime and N-acetyl-cysteine for the treatment of maxillary sinusitis in children with respiratory allergy.
Topics: Acetylcysteine; Adolescent; Asthma; Cefuroxime; Cephalosporins; Child; Chronic Disease; Drug Therapy | 1984 |
Antibiotic concentration in the exudate of venous ulcers: the prediction of ulcer healing rate.
Topics: Bed Rest; Cefuroxime; Cephalosporins; Chronic Disease; Diffusion; Female; Femoral Artery; Humans; Is | 1983 |
Unexpected side effects of cefuroxime lysine, a new cefuroxime salt.
Topics: Aged; Cefuroxime; Cephalosporins; Chronic Disease; Female; Humans; Male; Middle Aged; Osteomyelitis | 1980 |
Staging of chronic hyperplastic rhinosinusitis: treatment strategies.
Topics: Beclomethasone; Cefuroxime; Chronic Disease; Clinical Protocols; Combined Modality Therapy; Ethmoid | 1995 |
[Sultamicillin and cefuroxime axetil in the ambulatory treatment of exacerbated chronic bronchitis].
Topics: Adult; Ampicillin; Bronchitis; Cefuroxime; Chronic Disease; Drug Therapy, Combination; Female; Human | 1993 |
[Efficacy and tolerance of axetil cefuroxime for treatment of chronic urinary tract infection relapse in patients with diabetes mellitus].
Topics: Adult; Cefuroxime; Chronic Disease; Diabetic Nephropathies; Female; Humans; Male; Recurrence; Urinar | 1996 |
Pancoast's syndrome due to chronic pneumonia by Pasteurella multocida.
Topics: Adult; Cefuroxime; Cephalosporins; Chronic Disease; Diagnosis, Differential; Humans; Male; Pancoast | 1997 |
[Microbiological evaluation of antibiotics for empirical therapy of community-acquired infections of the lower respiratory tract].
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Bronchitis; Cefuroxime; Cepha | 2000 |
A simple infection model using pre-colonized implants to reproduce rat chronic Staphylococcus aureus osteomyelitis and study antibiotic treatment.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Cefuroxime; Cephalosporins; Chronic | 2001 |
[Cefuroxime axetil in the treatment of lower respiratory tract infections in patients with chronic lung diseases].
Topics: Aged; Cefuroxime; Chronic Disease; Drug Evaluation; Humans; Lung Diseases; Male; Middle Aged; Respir | 1992 |
[Binding of cefuroxime to macromolecules from bronchitic sputum in patients with chronic bronchitis].
Topics: Bronchitis; Cefuroxime; Chromatography, High Pressure Liquid; Chronic Disease; Humans; In Vitro Tech | 1991 |
Concentration of cefuroxime in serum and middle ear effusion after single dose treatment with cefuroxime axetil.
Topics: Acute Disease; Administration, Oral; Cefuroxime; Child; Chronic Disease; Exudates and Transudates; F | 1991 |
Physiopathological rationale and clinical aims of the use of a combination of cefuroxime and N-acetylcysteine in pneumology.
Topics: Acetylcysteine; Aged; Bronchi; Bronchial Diseases; Cefuroxime; Cephalosporins; Chronic Disease; Drug | 1985 |
Acute and exacerbated chronic respiratory tract infections: treatment with a combination of cefuroxime and acetylcysteine.
Topics: Acetylcysteine; Acute Disease; Adolescent; Adult; Aged; Cefuroxime; Cephalosporins; Chronic Disease; | 1985 |